Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Revenue projections:

Revenue projections for STE
Revenue projections for STE

STE's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 2.479000
forwardPE 21.491684
debtToEquity 28.651000
earningsGrowth 0.121000
revenueGrowth 0.092000
grossMargins 0.443220
operatingMargins 0.184940
trailingEps 7.180000
forwardEps 11.097780

STE's current ratio being 2.479 suggests that it has more than enough liquidity to cover short-term debt obligations. The company's cash reserves and current assets are sufficient to meet immediate liabilities, signaling solid financial health and minimal risk.
STE's Forward PE being in a good range indicates that the stock is valued appropriately based on its earnings. This suggests the stock is not overpriced and leaves room for growth, providing investors with an opportunity for potential appreciation in value.
STE's low Debt-to-Equity ratio suggests the company is minimally leveraged, with limited reliance on debt to finance its operations. This reduced financial risk positions the company for greater stability and financial health, appealing to investors who value conservative financial management.
STE's forward EPS is greater than its trailing EPS, indicating that the company is expected to deliver higher profitability this year. This suggests that STE is projected to improve its earnings, reflecting positive growth compared to last year's financial performance.

Price projections:

Price projections for STE
Price projections for STE

Over time, price projections for STE have gradually increased, reflecting rising confidence in the company's future performance. This upward trend suggests analysts expect STE to continue on a positive growth trajectory.

Insider Transactions:

Insider Transactions for STE
Insider Transactions for STE


9 sales of STE stock were made, with market price at 250.46555752224393 per share.The period under consideration saw no sell transactions.With more buys than sells around STERIS plc's current price, there seems to be increased confidence among investors. This shift may indicate a favorable outlook, as the buying behavior suggests optimism for the stock's future growth or resilience.

Recommendation changes over time:

Recommendations trend for STE
Recommendations trend for STE


Analysts are favoring STERIS plc with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider STERIS plc as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.